Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's Lymphoma
Stopped Genitope suspend drug development by decision made by the FDA March 6, 2008.
Conditions
Interventions
- BIOLOGICAL: autologous tumor cell vaccine
- BIOLOGICAL: keyhole limpet hemocyanin
- BIOLOGICAL: sargramostim
- PROCEDURE: adjuvant therapy
Sponsor
University of Nebraska